SCA and SDB With Coronary Spasm
pital or a defibrillator within the hospital. SCA was considered to be due to CS according to the following criteria: (1) documented VF or sustained rapid VT; (2) absence of significant coronary atherosclerotic lesion or structural cardiac abnormalities; (3) angiographic evidence of CS occurring spontaneously or induced by acetylcholine (ACh) provocation test; (4) absence of identifiable or causes of ventricular arrhythmias such as pre-excitation syndromes, long QT syndrome, metabolite or electrolyte disturbances or drug toxicity. 12,13, 18 In addition, patients with major cardiovascular diseases, including acute coronary syndrome, aortic dissection, pulmonary thromboembolism, myocarditis, cardiomyopathy, valvular heart disease, Figure. Patients with coronary artery spasm either complicated by a prior history of sudden cardiac arrest (SCA group) or without such a history (no-SCA group). 
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and specific electrophysiological abnormalities, and non-cardiac diseases, including hormonal and electrolyte abnormalities, were excluded.
Diagnosis of CS
CS was diagnosed by ACh provocation test according to the Japanese Circulation Society's guidelines for the diagnosis and treatment of patients with vasospastic angina. 18 Typical symptoms of CS were as follows: (1) chest pain or oppression typically occurring at rest during the night and early morning and not induced by strenuous exercise during the day; and (2) similar symptoms induced by ACh provocation test performed in the morning at least 48 h after the last administration of antianginal drugs in all eligible patients. A temporary pacing electrode was inserted into the right ventricle. Coronary angiography was performed before and after the injection of 20, 50 and 100 μg ACh in physiological saline into the left coronary artery and 20 and 50 μg into the right coronary artery. Coronary artery diameter was measured at baseline and at 1 and 3 min after each injection. ACh-induced CS was defined as "transient and total or subtotal occlusion (≥99% stenosis) of the coronary artery with ischemic ST-T changes on the electrocardiogram (ECG)". "Multivessel spasm" was defined as the presence of CS in more than 2 major coronary arteries.
Polysomnography
An overnight sleep study was performed for all patients during the stable period of CS. All patients were monitored by a por- Values are presented as n (%) or mean ± SD. LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; CS, coronary artery spasm; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker. Other abbreviations as in Table 1 . Ambulatory ECG Heart rate variability (HRV) was analyzed to assess autonomic nerve activity by ambulatory 3-channel ECG. R-R intervals with sinus rhythm, excluding arrhythmia, during the night were assessed using fast-Fourier transform. The frequency-domain measurements of HRV were assessed by low-frequency power (LF: changes in the RR interval at 0.04-9.15 Hz), high-frequency power (HF: changes in the RR interval at 0.15-0.40 Hz) and very-low-frequency power (VLF: changes in the RR interval at 0-0.05 Hz). 22,23 HF and LF/HF were used as indices of vagal activity and sympathetic activity, respectively. In addition, VLF represented the cyclic variation of HR associated with SDB. 24
Statistical Analysis
Logistic regression analysis was performed to assess associations between clinical variables and SCA. Ambulatory ECG data were analyzed by a nonparametric method, the Wilcoxon test. Any candidate variable with a value of P<0.05 after univariate screening was forced into a multivariate model, which then identified independent predictors of SCA defined by a multivariate value of P<0.05. The risk for SCA is presented as the odds ratio with 95% confidence interval (CI). Data are presented as mean ± SD.
Results

Patients' Characteristics
The clinical information regarding the onset of the fatal events in the SCA group of patients is shown in Table 1 . All patients with CS in the SCA group had attacks during sleep or at rest and between midnight and early in the morning (from 0 to 7:00 hours). An ACh provocation test was performed during the stable period after more than 14 days (27.4±11.1 days) from the onset of fatal events in the SCA group. The clinical characteristics of the CS patients with and without a prior history of aborted SCA were compared ( Table 2) . Demographic characteristics were similar between groups, and the prevalence of hypertension and diabetes mellitus did not differ between groups. Serum lipids, eGFR and LVEF were also comparable between groups. The minimal dose of ACh provoking CS did not differ between groups, but the number of prior angina attacks was significantly greater in patients without a prior aborted SCA. Multivessel spasm was significantly higher in the patients with CS and a prior history of SCA. Medication use before admission, including calcium antagonists and nitrates, was higher in the no-SCA group than in the SCA group, but did not reach statistical significance.
Among the patients with CS and a prior history of SCA, 1 (10%) required an intra-aortic balloon pump and 1 (10%) required percutaneous cardiopulmonary support for resuscitation. An implantable cardioverter-defibrillator was implanted in all 9 patients who had CS and a prior history of SCA. 
Association Between SDB and CS
The overall prevalence of moderate to severe SDB defined as AHI ≥15 was 45.8%. Moreover, moderate to severe SDB was significantly greater in the SCA than in the no-SCA group ( Table 3) . The OSA index was higher in the SCA group, but did not reach statistical significance between groups. The central sleep apnea (CSA) index was not significantly different between groups. The OSA index was significantly higher than the CSA index in patients with CS and a prior history of aborted SCA (8.67 vs. 1.02, P=0.04). The lowest SPO2 and longest apnea did not significantly differ between the SCA and no-SCA groups.
Clinical Predictors of SCA
Logistic regression analysis identified the risk factors for SCA among patients who had CS ( Tables 4,5 ). Multivariate logistic regression showed that moderate to severe SDB (odds ratio (OR) 38; 95% CI 2.80-1,498.24) and the number of prior anginal attacks (OR 0.75; 95% CI 0.37-0.96) were independently associated with SCA in patients with CS.
HRV Analysis
HRV analysis showed that average HR, non-sustained VT, and the frequency-domain parameters (LF/HF, HF, and VLF) did not significantly differ between the SCA and no-SCA groups (Table 6) . VLF, an index of the cyclic variation in HR induced by SDB, significantly correlated with AHI, but LF/HF and HF did not correlate with a prior history of aborted SCA in patients with CS ( Table 7) .
Discussion
This is the first study to demonstrate that SDB is a risk for SCA in patients who have CS. Furthermore, SDB was associated with autonomic instability, which might contribute to the increased risk of SCA in these patients.
SDB, especially OSA, is observed in approximately one-third of patients with a coronary artery disease. 25 However, there is little information about the relationship between CS and SDB. The present study demonstrated that SDB was associated with CS. Furthermore, the prevalence of moderate to severe SDB was significantly higher in patients with CS and a prior history of SCA. These results are consistent with those reported by Tamura et al, in whose study the prevalence of moderate to severe OSA was 66.7% among patients with CS. 26 Those authors also suggested that OSA might be an independent predisposing factor for CS.
There are several possible explanations for the association between CS and SDB. First, repetitive hypoxia/re-oxygenation increases the concentration of reactive oxygen species and reduces the availability of endothelial nitric oxide, resulting in endothelial dysfunction, 27,28 which can induce CS. Second, parasympathetic nervous activation followed by sympathetic nervous activation during episodes of SDB can increase the vascular tone of the epicardial coronary arteries with pre-existing endothelial dysfunction. 29, 30 Therefore, repetitive hypoxia, instability of the autonomic nervous system, and increased vascular tone due to SDB may all act as a trigger or substrate for fatal tachyarrhythmia and CS. VLF, an index of the cyclic variation in HR induced by SDB, significantly correlated with the AHI in the present patients with a prior history of SCA. Therefore, a rapid and unstable respiratory pattern during sleep might cause unstable vagal nerve activity via a pulmonary stretch receptor and thereby induce the production of ACh, resulting in CS in patients with endothelial dysfunction. The causes of SCA in patients with CS and a prior history of aborted SCA were mainly VF, not bradyarrhythmias, in the present study. However, we cannot not completely exclude the role of bradyarrhythmias because they were recognized in some patients with SDB. Bradyarrhythmias are more frequent during rapid eye movement sleep and their severity is exacerbated by episodes of marked hypoxemia during sleep. 31 Increased vagal tone associated with hypoxemia-induced carotid body stimulation has been implicated as the underlying mechanism of bradyarrhythmias. On the other hand, the mechanisms responsible for the association between SDB and tachyarrhythmias in SCA remain unclear. Therefore, SDB may be a trigger and not a direct independent predisposing factor. In other words, SDB may promote other underlying mechanisms, including CS, during sleep and thereby secondarily cause fatal tachyarrhythmias or SCA. Instability of the autonomic nervous system induced by a frequent and unstable respiratory pattern due to SDB may potentiate CS. It is possible that the duration, degree or extent of myocardial ischemia and ischemic preconditioning differ between patients with CS and a prior or no history of SCA. In the present study, the patients with CS and a prior history of HR, heart rate; NSVT, non-sustained ventricular tachycardia; LF, low-frequency power; HF, high-frequency power; VLF, very-low-frequency power. Other abbreviation as in Table 1 . Tables 1,3 ,4,6. SCA and SDB With Coronary Spasm SCA had obviously fewer numbers of prior anginal attacks and 88.9% of patients had multivessel spasm. These data suggest the presence of silent multivessel spasm. Prolonged, silent and multivessel CS might result in fatal arrhythmias and SCA. Paradoxically, the patients with CS in the no-SCA group had experienced more prior angina attacks and been prescribed prophylactic medications to relieve such attacks, which might have protected them from the occurrence of fatal events.
Study Limitations
There are several that need to be acknowledged. First, the cardiorespiratory portable monitoring device (Morpheus) was used and it could not record electroencephalograms in the present study. However, the quality of the oximeter signal of this device was proved to be valid in comparison with polysomnography. 19,32 Second, we could not obtain direct, simultaneous evidence of ischemic ST-T changes induced by CS during SDB. However, SCA was considered to be obviously due to CS because the patients had no other conditions or diseases to cause SCA. Third, patients with CS in the SCA group were taking fewer medications than those in the no-SCA group before admission. Patients in the SCA group had fewer medications than those in the no-SCA group before admission. Therefore, we could not completely exclude the possibility that these patients had SCA because they did not have sufficient medication. However, 8 patients with hypertension, dyslipidemia or diabetes mellitus had regular annual health check-ups and undertook life style modifications, and 1 patient with hypertension and dyslipidemia was regularly seen by a primary care physician every month. We thus considered that all patients in the SCA group were clinically well controlled despite fewer medications. Fourth, other factors such as older age and hypertension might also contribute to the high prevalence of SDB in our study patients. SDB (AHI ≥5) has been reported as present in approximately half the people aged 60-70 years 33 and 30% of patients with hypertension have SDB. 34 Therefore, the present study used the criterion of moderate or severe SDB (AHI ≥15) as indicative of the presence of SDB. Fifth, the sample size was small. If we can assume a strong effect of exposure on outcome (eg, OR=32 in the present study) with an incidence probability of 0.08 in the moderate to severe SDB group, a sample size of 22 is needed to detect the effect with 80% power and 0.05 of 2-sided significance level in a chi-square test. However, if we need to adjust by other confounders or evaluate more moderate effects with more narrow CI, a larger sample size is definitely needed to perform the multivariate logistic analysis (at least 34 and 64 are needed for OR ratio=16 and 8, respectively). Finally, Togashi et al reported that survival of SCA due to CS occurs frequently (57%) during the daytime. 35 However, the present study revealed that fatal events probably due to CS happened mainly at night or in the early morning. This discrepancy may be associated with the duration, degree, or extent of myocardial ischemia and ischemic preconditioning in patients who have CS with SDB. Therefore, further studies are needed to confirm the present results in a larger population.
Conclusions
The higher incidence of SDB in patients with CS may be conceivably related to the occurrence of SCA. Furthermore, autonomic instability during sleep can potentiate the risk of SCA at midnight or early in the morning. It may be necessary to identify patients with moderate to severe SDB among those with CS by screening with a cardiorespiratory monitor and recommend appropriate treatment for respiratory support as well as medical therapy in these high-risk patients.
